Clinical Trial Update: Home Based Infusions for Ocrelizumab [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating home-based infusions of ocrelizumab for multiple sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University of Colorado, Denver | Conditions: Multiple Sclerosis | Phase 4 | Status: RECRUITING